1Krussel JS, Bchr B, MilkiA, et al. Vascularendothclial growth factor VEGF mRNA, splice variants are differentially expressed in human blastocysts [J]. Mol Hum, Reprod, 2001, (7): 57263.
2Koizumi T, Shiraishi T, Hagihara N, et al. Expression of vascular endothelial growth factors and their receptors in and around intracranial malformations. Neurosurgery, 2002, 50 (1) : 1171.
3CooperME, VranesD, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR -2 in experimental diabetes [ J]. DiaBetes, 1999, 48:2229 - 2239
4Tsuzuki Y, Fukumura D, Oosthuyse B, et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia - induceiBle factor - 1a hypoxia response element VEGFcascade differently regulates vascular response and growth rat eintumors. CancerRes, 2000, (60) : 6248 -6252.
6Tsuzuki Y, Fukumura D, Oosthuyse B, et al. Vascular endothelial growth factor (VEGF) modulation By. targeting hypoxia - induceible factor - 1a hypoxia response element VEGFcascade differently regulates vascular response and growth rat eintumors [ J]. Cancer Res, 2000, 60 : 6248 - 6252.
7Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end product - induced apoptosisand over expression of vascular endothelial growth factor and monocyte chemoattractantprotein - 1 in human - cultured mesangial cell [J]. J Biol Chem, 2002, 277: 20309-20315.
8Duraisamy S, Goutamg C, Colby M, et al. Epithelial cells: a potential role in diabetic nephropathy [ J]. Kidneylnt, 2003, 64 (2) : 468 - 479.
9Rizkalla B, ForBes JM, Cao Z, et al. Temporal renal expression of angiogenic growth factors and their receptors in experimenta 1 diabetes: role of the rennin - angiotensinsystem [ J ]. Jhypertens, 2005, 23 (1): 153-164.
10Treins C, Giorgetti - Peraldi G, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation endproducts [J]. Biol Chem, 2001, 276 (47) : 48836 -43841.
7Cha DR, Kim NH, Yoon JW et al. Role of vascular endothelial growth factor in diabetic nephropathy.Kidney International,2000;58 77(Suppl): 104～12.
8Choi YJ, Chakraborty S, Nguyen V et al.Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney:altered expression of vascular endothelial growth factor. Human Pathology, 2000;31(12):1491～97.
9Bortoloso E,Del-prete D,Gambaro G et al.VEGF and VEGF receptors in diabetic patients.Ren Fail,2001;23(3-4):483～93.
10Feng Y,Venema VJ,Venema RC et al. Vascular endothelial growth factor induced permeability increase is mediated by caveoloe. Invest Ophthamol Vis Sic,1999;40(1):157～67.
3Mora C, Navarro J F. The role of inflammation as a pathogenic fac- tor in the development of renal disease in diabetes[J].Curr Diab Rep,2005 ,5( 6 ) :399-401.
4Valentfn M, Bueno B, Gutierrez E, et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. Nefrologia, 2004,24:43-48.
5邹万蕊.王海燕,主编..肾活检病理学.第1版.北京:北京大学医学出版社.2009,39-47.
6王迪浔,金惠铭.人体病理生理学.第3版.北京:人民卫生出版社.2008.3.
7Vargas F, Moreno JM, Rodrtguez-G6mez I, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol, 2006, 154:197-212.
8Nikolaeva AV, Pimenov LT. Functional renal status in patients with hypothyroidism. Klin Med ( Mosk), 1999,77:21-22.
9Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int, 2004,65 : 2003 -2017.
10Kim BS, Goligorsky MS. Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease. Korean J Intern Med, 2003,18:65-75.
